Erythropoietin Prevents Blood Brain Barrier Damage Induced by Focal Cerebral Ischemia in Mice (original) (raw)
Hawkins BT, Davis TP (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173–185 ArticleCASPubMed Google Scholar
Ballabh P, Braun A, Nedergaard M (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16:1–13 ArticleCASPubMed Google Scholar
Dejana E, Corada M, Lampugnani MG (1995) Endothelial cell-to-cell junctions. Faseb J 9:910–918 CASPubMed Google Scholar
Neuwelt EA (2004) Mechanisms of disease: the blood-brain barrier. Neurosurgery 54:131–140; discussion 141–132 ArticlePubMed Google Scholar
Fischer S, Clauss M, Wiesnet M et al. (1999) Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am J Physiol 276:C812–C820 CASPubMed Google Scholar
Fischer S, Wobben M, Marti HH et al. (2002) Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 63:70–80 ArticleCASPubMed Google Scholar
Wang W, Dentler WL, Borchardt RT (2001) VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol 280:H434–440 CASPubMed Google Scholar
Chi OZ, Hunter C, Liu X et al (2007) Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia. Exp Neurol 204:283–287 ArticleCASPubMed Google Scholar
Genc S, Koroglu TF, Genc K (2004) Erythropoietin as a novel neuroprotectant. Restorat Neurol Neurosci 22:105–119 CAS Google Scholar
Wang L, Zhang Z, Wang Y et al. (2004) Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke; a J Cerebral Circul 35:1732–1737 CAS Google Scholar
Bartesaghi S, Marinovich M, Corsini E et al. (2005) Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology 26:923–928 ArticleCASPubMed Google Scholar
Li Y, Lu Z, Keogh CL et al. (2006) Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab 27(5):1043–1054 PubMed Google Scholar
Wang W, Merrill MJ, Borchardt RT (1996) Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro. Am J Physiol 271:C1973–1980 CASPubMed Google Scholar
Dvorak HF, Brown LF, Detmar M et al. (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol146:1029–1039 Google Scholar
Shalaby F, Rossant J, Yamaguchi TP et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62–66 ArticleCASPubMed Google Scholar
Weis SM, Cheresh DA (2005) Pathophysiological consequences of VEGF–induced vascular permeability. Nature 437:497–504 ArticleCASPubMed Google Scholar
Lafuente JV, Argandona EG, Mitre B (2006) VEGFR-2 expression in brain injury: its distribution related to brain-blood barrier markers. J Neural Transm 113:487–496 ArticleCASPubMed Google Scholar
Hillman NJ, Whittles CE, Pocock TM et al. (2001) Differential effects of vascular endothelial growth factor-C and placental growth factor-1 on the hydraulic conductivity of frog mesenteric capillaries. J Vasc Res 38:176–186 ArticleCASPubMed Google Scholar
Wei L, Cui L, Snider BJ et al. (2005) Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol Dis 19:183–193 ArticleCASPubMed Google Scholar
Calapai G, Marciano MC, Corica F et al. (2000) Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol 401:349–356 ArticleCASPubMed Google Scholar
Fandrey J (2004) Oxygen–dependent and tissue-specific regulation of erythropoietin gene expression. Am J Physiol Regul Integr Comp Physiol 286:R977–988 CASPubMed Google Scholar
Wei L, Han BH, Li Y et al. (2006) Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J Pharmacol Experiment Therapeut 317:109–116 ArticleCAS Google Scholar
Bates DO, Hillman NJ, Williams B et al. (2002) Regulation of microvascular permeability by vascular endothelial growth factors. J Anat 200:581–597 ArticleCASPubMed Google Scholar
Martinez-Estrada OM, Rodriguez-Millan E, Gonzalez-De Vicente E et al. (2003) Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 18:2538–2544 ArticlePubMed Google Scholar
Uzum G, Sarper Diler A, Bahcekapili N et al. (2006) Erythropoietin prevents the increase in blood-brain barrier permeability during pentylentetrazol induced seizures. Life Sci 78:2571–2576 ArticlePubMedCAS Google Scholar
Bahcekapili N, Uzum G, Gokkusu C et al. (2007) The relationship between erythropoietin pretreatment with blood-brain barrier and lipid peroxidation after ischemia/reperfusion in rats. Life Sci 80:1245–1251 ArticleCASPubMed Google Scholar
Andras IE, Deli MA, Veszelka S et al. (2007) The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J Cereb Blood Flow Metab
Hawkins BT, Lundeen TF, Norwood KM et al. (2007) Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 50:202–211 ArticleCASPubMed Google Scholar
Neufeld G, Cohen T, Gengrinovitch S et al. (1999) Vascular endothelial growth factor (VEGF) and its receptors. Faseb J 13:9–22 CASPubMed Google Scholar
Park JE, Chen HH, Winer J et al. (1994) Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biolog Chem 269:25646–25654 CAS Google Scholar
Joukov V, Pajusola K, Kaipainen A et al. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290–298 CASPubMed Google Scholar
Bauters C, Asahara T, Zheng LP et al. (1995) Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg 21:314–324; discussion 324–315 ArticleCASPubMed Google Scholar
Brogi E, Schatteman G, Wu T et al. (1996) Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Investig 97:469–476 ArticleCASPubMed Google Scholar
Shibuya M (2006) Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E. Endothelium 13:63–69 ArticleCASPubMed Google Scholar
Board RE, Thistlethwaite FC, Hawkins RE (2007) Anti-angiogenic therapy in the treatment of advanced renal cell cancer. Cancer Treatt Rev 33:1–8 ArticleCAS Google Scholar
Takagi H, King GL, Ferrara N et al. (1996) Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Investig Ophthalmol Visual Science 37:1311–1321 CAS Google Scholar